17
Dec
Dec
Are GLP-1 Drugs Worth It in 2026? Real Results
-
Mark Burton / 4 months
- 0
- 5 min read
Are GLP-1 Drugs Worth It in 2026? Real Results As 2026 begins, GLP-1 receptor agonists—medications like Ozempic, Wegovy, Mounjaro, and Zepbound—remain at the forefront of weight loss and metabolic health treatments. These injectable (and soon oral) drugs mimic the hormone GLP-1 to increase satiety, slow gastric emptying, and enhance insulin response, delivering average weight loss of […]